Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-07

Clinical Trial Update: Zoster Eye Disease Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating Zoster Eye Disease for Herpes Zoster Ophthalmicus has completed, with results posted on March 7, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Herpes Zoster Ophthalmicus | Phase 4 | Status: COMPLETED | Results posted: 2025-03-07